Cheval Holdings, Ltd.
- SEC CIK
- 0001679225
No open-market purchases or sales filed in the past year.
Current role at each company
- HGEN Humanigen, Inc10% Owneras of Oct 20, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cheval Holdings, Ltd. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2023 (view filing)6:50 PM ET | Oct 18 | 2 days | Chappell Dale and 4 othersChief Scientific Officer | SSaleCommon Stock, $0.001 par value | −386.4K | $0.011 | −$4.25K | −4.4%8.40M after | 3 lots |
| May 20, 2022 (view filing)5:57 PM ET | May 18-20 | 2 days | Chappell Dale and 4 othersChief Scientific Officer | PPurchaseCommon Stock, $0.001 par value | +1.04M | $2.17 | +$2.26M | +13.7%8.68M after | 9 lots |
| Mar 15, 2022 (view filing)6:23 PM ET | Mar 11 | 4 days | Chappell Dale and 4 othersChief Scientific Officer | PPurchaseCommon Stock, $0.001 par value | +1.00M | $3.00 | +$3.00M | +14.4%7.94M after | 3 lots |
| Mar 10, 2022 (view filing)7:24 PM ET | Mar 8-10 | 2 days | Chappell Dale and 4 othersChief Scientific Officer | PPurchaseCommon Stock, $0.001 par value | +468.5K | $0.01 | +$4.66K | –2.87K after | Derivative12 lots |
| Mar 4, 2022 (view filing)6:42 PM ET | Mar 2-4 | 2 days | Chappell Dale and 4 othersChief Scientific Officer | PPurchaseCommon Stock, $0.001 par value | +996.8K | $0.0059 | +$5.87K | –5.69K after | Derivative15 lots |
| Aug 13, 2021 (view filing)9:28 PM ET | Aug 11-12 | 2 days | Chappell Dale and 4 othersChief Scientific Officer | SSaleCommon Stock, $0.001 par value | −167.2K | $17.10 | −$2.86M | −2.2%7.27M after | 6 lots |
| Jul 30, 2021 (view filing)9:01 PM ET | Jul 28-29 | 2 days | Chappell Dale and 4 othersChief Scientific Officer | SSaleCommon Stock, $0.001 par value | −39.1K | $17.04 | −$665.9K | −0.5%7.37M after | 6 lots |
| Jul 23, 2021 (view filing)8:32 PM ET | Jul 21-23 | 2 days | Chappell Dale and 4 othersChief Scientific Officer | SSaleCommon Stock, $0.001 par value | −316.4K | $17.08 | −$5.40M | −4.1%7.39M after | 9 lots |
| Jul 16, 2021 (view filing)8:28 PM ET | Jul 14 | 2 days | Chappell Dale and 4 othersChief Scientific Officer | SSaleCommon Stock, $0.001 par value | −15.2K | $17.06 | −$258.8K | −0.2%7.62M after | 3 lots |
| Jul 9, 2021 (view filing)9:01 PM ET | Jul 8-9 | 1 day | Chappell Dale and 4 othersChief Scientific Officer | SSaleCommon Stock, $0.001 par value | −344.0K | $17.34 | −$5.97M | −4.3%7.63M after | 6 lots |
| Jul 2, 2021 (view filing)5:44 PM ET | Jun 30-Jul 2 | 2 days | Chappell Dale and 4 othersChief Scientific Officer | SSaleCommon Stock, $0.001 par value | −463.1K | $17.19 | −$7.96M | −5.5%7.88M after | 9 lots |